NeoGenomics (NEO)

• Market cap: $1.28B
• 1 day: -1.2%
• 5 days: -12.63%
• 1 month: -21.76%
• 3 months: -6.7%
• 6 months: 62.13%
• Year to date: -15.9%
• 1 year: -16.61%
• 5 years: -81.52%
• 10 years: 60.29%
• Sector: Healthcare
• Industry: Diagnostics & Research

About: NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

Employees: 2,200